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clinical program. The New Patient Referral (NPR) team has been
working diligently to meet the needs of community physicians who
refer patients for blood and marrow transplantation (BMT).
In an effort to improve the referral process and increase RP
satisfaction, the BMT- NPR team collaborated with the Ofﬁce of
Physician Relations in a process improvement project which re-
sulted in the creation of a Satisfaction Survey Tool (SST). The
information obtained from the SST reﬂected the perception of the
RP on telephone courtesy, promptness and efﬁciency in returning
initial referral call and timely referral facilitation serving as the
baseline level of performance. Community physicians who have
referred a BMT patient within the previous 12 months received the
survey tool. Of the 13% returned, the overall results were positive
with areas for improvement identiﬁed. The Referral Team devel-
oped strategies based on the survey feedback: (1) customer service
training for the Referral Team performed by a consultant skilled in
physician-referral program; (2) revision of the Medical Acceptance
Criteria and policy that guides the NPR team regarding clinical
information needed for medical review; (3) development of an
algorithm on the Referral Process that includes a telephone script
for answering referrals; (4) development of a Referral Notiﬁcation
Letter that serves as a thank you note; and (5) development of an
on-line referral for physicians. The improvement strategies have
resulted in a more organized and consistent NPR process. The
staff has been encouraged by the verbal feedback of the RP regard-
ing the smooth processing of referrals. A follow-up survey will be
sent to the RP to evaluate if the improvements resulted in a positive
difference in the process as evidenced by improved communication
and ease of access.
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INFECTIOUS COMPLICATIONS OF THE GASTROINTESTINAL TRACT IN
THE ALLOGENEIC BMT PATIENT
Metoyer, L.J., Westmoreland, M.D. The University of Texas M. D.
Anderson Cancer Center, Houston, TX.
Gastrointestinal (GI) tract complications in the bone marrow
transplant patient can be a clinical challenge for both the patient
and their clinician. Although the majority of these complications
are a direct result of acute graft versus host disease, there are other
infectious etiologies that often mimic these clinical signs and symp-
toms and ultimately prove to be equally detrimental. In general,
the lack of speciﬁc pathogen identiﬁcation, adequate cultures and
deﬁnitive pathology, often prove difﬁcult, thus leaving the clinician
with uncertainty as to appropriate treatment modalities. This pre-
sentation will discuss three challenging clinical presentations of
gastrointestinal complications in the BMT patient that highlight
interesting infectious complications. Three infectious diagnoses
will be discussed in detail including pneumatosis intestinalis due to
resistant cytomegalovirus colitis, strongyloidiasis and resistant her-
pes simplex. Each case presentation will include a brief overview of
the patient demographics, the primary diagnosis, and the trans-
plant course. The primary focus of the case discussions will be on
the presentation of gastrointestinal signs and symptoms, and dif-
ferential diagnosis. Treatment options for each case as well as the
treatment course and resulting outcomes will be discussed. Speciﬁc
pharmacologic treatments of interest will include Cidofovir, Iver-
mectin, and Abendazole.
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TWO SIBLINGS IN NEED OF AN HEMATOPOIETIC STEM CELL TRANS-
PLANT (HSCT): CONSIDERATIONS FOR TANDEM TRANSPLANTS
Vachon, M.-F., Lavigne, M.-J., Richer, J., Catalfamo, N., Mercier, G.,
Vandenbosch, K., Duval, M., Champagne, M.A. CHU Ste-Justine,
Montreal, QC, Canada.
In addition to the inherent stress to the patient and family,
HSCT carries a signiﬁcant transplant mortality risk. We describe
the experience of a family whose 2 of their 3 children needed a cord
blood HSCT within the next 6 months following the diagnosis of
a congenital MDS. Neither of them had been previously hospital-
ized nor exposed to a serious disease. Simultaneous or sequential
transplants were considered. Simultaneous transplants were at risk
to raise the overall difﬁculty of the experience but would shorten
the overall time period of restrictions following HSCT. Also, if the
ﬁrst of 2 planned sequential transplants had been unsuccessful,
there might have been a signiﬁcant negative impact on the family.
Also, everyone on the team was conscious of the potential risks
associated with doing two siblings at the same time (constant
comparison of the two, errors, etc.). The 2 options were discussed
with the family.
The family initially decided to proceed with sequential HSCT
but then instead chose simultaneous transplants. The HSCTs were
performed 2 days apart. The length of stay for the 4-year-old
daughter was 41 days: she fully engrafted without major compli-
cations. The 6-year-old son did not engraft and remained pancy-
topenic. A second HSCT was immediately performed: his total
stay was 105 days.
The two children are now more than 6 months post-HSCT with
Lansky scores of 100%, no evidence of GVHD and without im-
munosuppression. The parents still consider that they chose cor-
rectly in proceeding with simultaneous HSCT. However, they
recognize that it was a very difﬁcult experience. For example, they
feel that it was extremely difﬁcult to manage the family daily
routine, the preparation of the medications, and the restrictions
due to the immunosuppressed status of their children. Also, the
unexpected second HSCT needed by their son added to their
stress. They recognize that the support they received from their
extended families and the transplant team played a signiﬁcant role
in their adaptation to the situation. Among the facilitating mea-
sures implemented by the team, the children were hospitalized in
neighboring rooms sharing an anteroom. The parents were thus
able to visit both children more easily and the children were able to
visit each other.
In conclusion, if again confronted with the need to transplant 2
siblings, the most important factor to consider is the family’s
internal and external resources to face this difﬁcult and uncommon
experience.
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THE DEVELOPMENT OF THE LEAD TRANSPLANT COORDINATOR FOR
ONE OF THE LARGEST BLOOD AND MARROW TRANSPLANT CENTERS
IN THE COUNTRY
Koval, E.T., Adornetto-Garcia, D. The University of Texas M. D.
Anderson Cancer Center, Houston, TX.
A challenge for one of the largest blood and marrow transplant
centers in the country is the management of complex internal
communications associated with a highly diversiﬁed program.
With this diversiﬁcation comes a program that is divided into many
processes represented by a team of people that function as a
network to achieve a common goal. The pre-transplant phase is
one such process and is a complex, emotional experience for the
patient demanding the expertise of a BMT Coordinator Team
functioning at the center of the network. A Lead Transplant
Coordinator position was developed to provide support and lead-
ership to this team while addressing communication needs. The
Lead Transplant Coordinator functions as the team leader with
supervisory authority over 6 registered nurses and 1 assistant that
comprise the coordinator team. The supervisory role is further
divided into 5 distinct sets of responsibilities, which includes the
following: Human Resource Management, Collaboration and
Teamwork, Patient Education and Satisfaction, Stafﬁng and Pro-
fessional Education, and Regulatory Compliance including policy
and procedure review. While each coordinator is able to focus on
the coordination of care for the individual patient, the lead coor-
dinator focuses on the 5 individual sets of responsibilities and
ensures that the Coordinator Team is successfully delivering the
highest quality of professional service to both patients and col-
leagues. The lead coordinator meets on a regular basis with the
coordinator team, the program’s administrative director, medical
director, business center supervisor, and research nursing supervi-
sors to facilitate communication and collaboration amongst the
teams.
The outcome of this new structure represents the Coordinator
Team as a cohesive unit with a common set of team goals and a
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